INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42m ago
House PTR2m ago
SEC 13F2m ago
Robinhood Chain2m ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.58B / 21S · 3 late79 trades$24.55M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

65,929 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SK
Shacklett KimberlySVP, Customer Experience
MSMMSC INDUSTRIAL DIRECT CO INC
Tax withholding
F$32K
266 sh
Nov 3, 2026Nov 5, 2026
Page 44 of 1649
← PrevNext →
traded Nov 3, 2026
+2d
SEC Form 4

Evidence

9
SK
Shacklett KimberlySVP, Customer Experience
MSMMSC INDUSTRIAL DIRECT CO INC
Option exercise
M—
589 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
SK
Shacklett KimberlySVP, Customer Experience
MSMMSC INDUSTRIAL DIRECT CO INC
Tax withholding
F$30K
250 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
MA
McCallum Scott AndrewEVP-Chief Investment Officer
UDRUDR, Inc.
Grant or award
A—
111.3K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
SK
Shacklett KimberlySVP, Customer Experience
MSMMSC INDUSTRIAL DIRECT CO INC
Option exercise
M—
61 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
NS
Naranjo Alvarez SantiagoChief Revenue Officer
NYSEVTEXVTEX
Grant or award
A—
100.0K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
DG
do Carmo Thomaz Junior GeraldoChief Executive Officer
NYSEVTEXVTEX
Grant or award
A—
433.4K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
RE
Roberts EiryChief Medical Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
1,506 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

9
LM
Lisman MichaelDirector, President & CEO
TDGTransDigm Group INC
Grant or award
A—
4,214 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
LM
Lisman MichaelDirector, President & CEO
TDGTransDigm Group INC
Grant or award
A—
18.9K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
LM
Lisman MichaelDirector, President & CEO
TDGTransDigm Group INC
Grant or award
A—
30.9K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
LM
Lisman MichaelDirector, President & CEO
TDGTransDigm Group INC
Grant or award
A—
4,189 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
PR
Pickerill Alan RDirector
PRCHPorch Group, Inc.
Option exercise
M$8,850
5,000 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
FD
Federico Richard DDirector
ALNTALLIENT INC
Grant or award
A$28K
355 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

9
VR
Vondrasek Mark RSee Remarks
HHyatt Hotels Corp
Option exercise
M—
3,482 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

9
VR
Vondrasek Mark RSee Remarks
HHyatt Hotels Corp
Option exercise
M—
8,109 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

9
WE
Walther Donald E.Chief Legal Officer
CMTLCOMTECH TELECOMMUNICATIONS CORP /DE/
Grant or award
A—
528.5K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
ZY
Zoghbi Huda YDirector
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
7,439 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
FM
Farrell MatthewDirector
NOVTNOVANTA INC
Option exercise
M—
241 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
DW
Doran WilliamDirector
SEICSEI INVESTMENTS CO
Option exercise
M—
5,000 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

9
DW
Doran WilliamDirector
SEICSEI INVESTMENTS CO
Option exercise
M—
5,000 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

9
JJ
Joseph Fred J.Director
NBHCNational Bank Holdings Corp
Tax withholding
F$24K
652 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
BA
Boyd Lorie AnnChief People Officer
KDKKodiak AI, Inc.
Grant or award
A—
747.9K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
RW
Roberts Eric WDirector, CHIEF BUSINESS OFFICER
CALCCalciMedica, Inc.
Grant or award
A—
180.0K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
CN
Clase NeeraChief Commercial Officer
TARSTarsus Pharmaceuticals, Inc.
Grant or award
A—
6,678 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
PJ
Platt Ira J.Director
CVNACARVANA CO.
Option exercise
M—
15.0K sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

9
LM
Lisman MichaelDirector, President & CEO
TDGTransDigm Group INC
Grant or award
A—
1,053 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
SM
Santana MicheleDirector
TDGTransDigm Group INC
Grant or award
A—
589 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
GD
Gala Renee DDirector, President & CEO
JAZZJazz Pharmaceuticals plc
Open-market sale · 10b5-1 plan
SELL$225K
1,000 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
SF
Spring Maria FDirector
NBHCNational Bank Holdings Corp
Tax withholding
F$22K
583 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
PP
Palmer PeterDirector
TDGTransDigm Group INC
Grant or award
A—
589 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
WS
Wynne SarahChief Financial Officer
TDGTransDigm Group INC
Grant or award
A—
15.2K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
RP
Robertson Jeffery PaulPresident, Allerium Segment
CMTLCOMTECH TELECOMMUNICATIONS CORP /DE/
Grant or award
A—
198.2K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
JR
Jaye James RSVP - IR & Corp. Comm.
SHWSHERWIN WILLIAMS CO
Option exercise
M—
4,527 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
FM
Farrell MatthewDirector
NOVTNOVANTA INC
Option exercise
M—
241 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
RE
Roberts EiryChief Medical Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
8,314 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

9
DS
Dubey SharmisthaDirector
REALTheRealReal, Inc.
Grant or award
A—
7,831 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

9
HN
Howley W NicholasDirector
TDGTransDigm Group INC
Grant or award
A—
589 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

8
BC
Baker CoreyChief Financial Officer
COCOVita Coco Company, Inc.
Open-market sale · 10b5-1 plan
SELL$60K
1,000 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

8
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$563K
24.7K sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K